Stablepoint Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.13M | Buy |
22,237
+131
| +0.6% | +$24.3K | 0.7% | 52 |
|
|
2025
Q1 | $4.63M | Buy |
22,106
+396
| +2% | +$83K | 0.84% | 44 |
|
|
2024
Q4 | $3.86M | Buy |
21,710
+81
| +0.4% | +$14.4K | 0.71% | 51 |
|
|
2024
Q3 | $4.27M | Buy |
21,629
+171
| +0.8% | +$33.8K | 0.78% | 49 |
|
|
2024
Q2 | $3.9M | Sell |
21,458
-351
| -2% | -$63.9K | 0.76% | 52 |
|
|
2024
Q1 | $3.97M | Buy |
21,809
+4,420
| +25% | +$805K | 0.81% | 47 |
|
|
2023
Q4 | $2.69M | Buy |
+17,389
| New | +$2.69M | 0.69% | 52 |
|